Forte Biosciences Inc. buy krebskrebs
Start price
04.10.21
/
50%
€2.60
Target price
04.10.22
€5.00
Performance (%)
-58.69%
End price
05.10.22
€1.07
Summary
This prediction ended on 05.10.22 with a price of €1.07. Massive losses of -58.69% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Forte Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,95 % | 43,35 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 9,58 % | 72,42 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 20,32 % | 43,44 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 5,80 % | 54,98 % |
Comments by krebskrebs for this prediction
In the thread Tocagen diskutieren
In the thread Trading Tocagen
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten